Assessment of Motor Reserve in the Preclinical Stages of Dementia

  • STATUS
    Recruiting
  • End date
    Jul 9, 2027
  • participants needed
    200
  • sponsor
    Istituto per la Ricerca e l'Innovazione Biomedica
Send
Updated on 9 June 2026
See if I qualify
Accepts healthy volunteers

Summary

Mild Cognitive Impairment (MCI) is a clinical condition associated with an increased risk of progression to dementia. Although cognitive alterations have traditionally been the main focus of investigation, growing evidence suggests that motor changes may also emerge during the early stages of cognitive decline and may represent potential preclinical indicators of disease.

In this context, the concept of motor reserve has emerged as a construct of increasing interest, although it remains insufficiently defined. Understanding how motor characteristics may contribute to an individual's ability to compensate for or modulate the effects of cognitive decline could provide new insights into the mechanisms involved in the early stages of dementia.

Therefore, the present monocentric observational study aims to further investigate the concept of motor reserve in healthy individuals and in patients with Mild Cognitive Impairment (MCI) through a multidimensional approach based on clinical, neuropsychological, behavioral, and kinematic assessments. In particular, standardized motor tasks and quantitative movement analyses using a sensor-based medical device will be employed to objectively characterize motor performance.The study plans to recruit approximately 200 participants, including healthy individuals and patients with MCI, enrolled at the Neuropsychology Outpatient Clinic of the Neurology Unit of the University Hospital "Renato Dulbecco" in Catanzaro. In the healthy group, the relationship between motor reserve and motor performance will be investigated, while in patients with MCI the relationship between cognitive reserve, motor reserve, clinical and neuropsychological status, and motor performance will be explored.

The findings of this study may contribute to a broader and more operational definition of motor reserve and support the identification of potential motor biomarkers associated with early cognitive decline. These findings may ultimately contribute to the development of innovative strategies for the early detection and monitoring of conditions at risk of progression to dementia.

Details
Condition Mild Cognitive Impairment (MCI)
Age 18years - 85years
Clinical Study IdentifierNCT07634055
SponsorIstituto per la Ricerca e l'Innovazione Biomedica
Last Modified on9 June 2026

Eligibility

 Yes No Not Sure

Inclusion Criteria

Patients with Mild Cognitive Impairment (MCI) group
Diagnosis of MCI according to the international criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA) (Albert et al., 2011; McKhann et al., 2011)
Age between 40 and 85 years
Native Italian speaker or sufficient Italian language proficiency to understand the tests
Signed informed consent provided by the participant or by a legal representative
Healthy subjects group
Normal performance on the neuropsychological screening assessment. Age between 40 and 85 years
Native Italian speaker or sufficient Italian language proficiency to understand the tests
Signed informed consent

Exclusion Criteria

Patients with Mild Cognitive Impairment (MCI) group
History of psychiatric or neurological disorders not attributable to MCI. Use of psychotropic medications
Healthy subjects group
History of psychiatric or neurological disorders
Use of psychotropic medications
Disabling medical comorbidities or medical conditions interfering with motor function
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

Accepts healthy volunteers

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.